{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:37Z","timestamp":1740107317312,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["KJ2020A0171"],"award-info":[{"award-number":["KJ2020A0171"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation Training Program of The First Affiliated Hospital of Anhui Medical University","award":["2019KJ04"],"award-info":[{"award-number":["2019KJ04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-023-04426-5","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T01:01:41Z","timestamp":1685149301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of a nomogram to predict which patients with colorectal cancer liver metastases would benefit from primary tumor resection"],"prefix":"10.1007","volume":"38","author":[{"given":"Mingming","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenya","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,27]]},"reference":[{"key":"4426_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4426_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","volume":"72","author":"F Ciardiello","year":"2022","unstructured":"Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A (2022) Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin 72:372\u2013401. https:\/\/doi.org\/10.3322\/caac.21728","journal-title":"CA Cancer J Clin"},{"key":"4426_CR3","doi-asserted-by":"publisher","unstructured":"De Falco V, Napolitano S, Rosello S, Huerta M, Cervantes A, Ciardiello F, Troiani T (2020) How we treat metastatic colorectal cancer. ESMO Open 4:e000813. https:\/\/doi.org\/10.1136\/esmoopen-2020-000813","DOI":"10.1136\/esmoopen-2020-000813"},{"key":"4426_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamasurg.2019.1694","volume":"154","author":"J Datta","year":"2019","unstructured":"Datta J, Narayan RR, Kemeny NE, D\u2019Angelica MI (2019) Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review. JAMA Surg 154:768\u2013776. https:\/\/doi.org\/10.1001\/jamasurg.2019.1694","journal-title":"JAMA Surg"},{"key":"4426_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.critrevonc.2018.10.001","volume":"132","author":"F Gelsomino","year":"2018","unstructured":"Gelsomino F, Spallanzani A, Orsi G, Caputo F, Santini C, Cascinu S (2018) To resect or not to resect: the hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer. Crit Rev Oncol Hematol 132:154\u2013160. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.10.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"4426_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejca.2017.12.014","volume":"91","author":"KL van Rooijen","year":"2018","unstructured":"van Rooijen KL, Shi Q, Goey KKH, Meyers J, Heinemann V, Diaz-Rubio E, Aranda E, Falcone A, Green E, de Gramont A et al (2018) Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: individual patient data analysis of first-line randomised trials from the ARCAD database. Eur J Cancer 91:99\u2013106. https:\/\/doi.org\/10.1016\/j.ejca.2017.12.014","journal-title":"Eur J Cancer"},{"key":"4426_CR7","doi-asserted-by":"publisher","unstructured":"Colloca GA, Venturino A, Guarneri D (2022) Primary tumor resection in patients with unresectable colorectal cancer with synchronous metastases could improve the activity of poly-chemotherapy: a trial-level meta-analysis. Surg Oncol 44:101820. https:\/\/doi.org\/10.1016\/j.suronc.2022.101820","DOI":"10.1016\/j.suronc.2022.101820"},{"key":"4426_CR8","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/ijc.30244","volume":"139","author":"K Soreide","year":"2016","unstructured":"Soreide K (2016) Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials. Int J Cancer 139:1927\u20131929. https:\/\/doi.org\/10.1002\/ijc.30244","journal-title":"Int J Cancer"},{"key":"4426_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1200\/JCO.20.02447","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shitara K, Mizusawa J, Hamaguchi T, Shida D, Komori K, Ikeda S, Ojima H, Ike H, Shiomi A et al (2021) Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J Clin Oncol 39:1098\u20131107. https:\/\/doi.org\/10.1200\/JCO.20.02447","journal-title":"J Clin Oncol"},{"key":"4426_CR10","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/0008-5472.CAN-16-1536","volume":"77","author":"S Tohme","year":"2017","unstructured":"Tohme S, Simmons RL, Tsung A (2017) Surgery for cancer: a trigger for metastases. Cancer Res 77:1548\u20131552. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1536","journal-title":"Cancer Res"},{"key":"4426_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/codi.13123","volume":"18","author":"ZM Li","year":"2016","unstructured":"Li ZM, Peng YF, Du CZ, Gu J (2016) Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection. Colorectal Dis 18:255\u2013263. https:\/\/doi.org\/10.1111\/codi.13123","journal-title":"Colorectal Dis"},{"key":"4426_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00384-015-2419-z","volume":"31","author":"SR Dorajoo","year":"2016","unstructured":"Dorajoo SR, Tan WJ, Koo SX, Tan WS, Chew MH, Tang CL, Wee HL, Yap CW (2016) A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis. Int J Colorectal Dis 31:235\u2013245. https:\/\/doi.org\/10.1007\/s00384-015-2419-z","journal-title":"Int J Colorectal Dis"},{"key":"4426_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q (2020) A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond) 40:301\u2013312. https:\/\/doi.org\/10.1002\/cac2.12067","journal-title":"Cancer Commun (Lond)"},{"key":"4426_CR14","doi-asserted-by":"publisher","unstructured":"Hu C-Y, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ (2015) Time trend analysis of primary tumor resection for stage IV colorectal cancer. JAMA Surg 150.\u00a0https:\/\/doi.org\/10.1001\/jamasurg.2014.2253","DOI":"10.1001\/jamasurg.2014.2253"},{"key":"4426_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/jjco\/hyz173","volume":"50","author":"K Moritani","year":"2020","unstructured":"Moritani K, Kanemitsu Y, Shida D, Shitara K, Mizusawa J, Katayama H, Hamaguchi T, Shimada Y (2020) A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study). Jpn J Clin Oncol 50:89\u201393. https:\/\/doi.org\/10.1093\/jjco\/hyz173","journal-title":"Jpn J Clin Oncol"},{"key":"4426_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.4251\/wjgo.v12.i11.1296","volume":"12","author":"Z Tharin","year":"2020","unstructured":"Tharin Z, Blanc J, Alaoui IC, Bertaut A, Ghiringhelli F (2020) Influence of primary tumor location and resection on survival in metastatic colorectal cancer. World J Gastrointest Oncol 12:1296\u20131310. https:\/\/doi.org\/10.4251\/wjgo.v12.i11.1296","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"4426_CR17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.7150\/jca.29294","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang X, Zhang Z, Wang X, Chen M, Lu L, Zhu W, Zhang J, Jia H, Chen J (2019) Association between primary tumor location and prognostic survival in synchronous colorectal liver metastases after surgical treatment: a retrospective analysis of SEER data. J Cancer 10:1593\u20131600. https:\/\/doi.org\/10.7150\/jca.29294","journal-title":"J Cancer"},{"key":"4426_CR18","doi-asserted-by":"publisher","unstructured":"Zhang R-X, Ma W-J, Gu Y-T, Zhang T-Q, Huang Z-M, Lu Z-H, Gu Y-K (2017) Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.\u00a0World J Gastrointest Oncol\u00a015.\u00a0https:\/\/doi.org\/10.1186\/s12957-017-1198-0","DOI":"10.1186\/s12957-017-1198-0"},{"key":"4426_CR19","doi-asserted-by":"publisher","unstructured":"Zhao J, Zhu J, Sun R, Huang C, Yuan R, Zhu Z (2021) Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis. BMC Cancer 21.\u00a0https:\/\/doi.org\/10.1186\/s12885-021-08157-0","DOI":"10.1186\/s12885-021-08157-0"},{"key":"4426_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/cncr.30230","volume":"123","author":"Z Alawadi","year":"2017","unstructured":"Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM et al (2017) Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer 123:1124\u20131133. https:\/\/doi.org\/10.1002\/cncr.30230","journal-title":"Cancer"},{"key":"4426_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.gie.2019.04.236","volume":"90","author":"JY Yang","year":"2019","unstructured":"Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, Sturmer T (2019) Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research. Gastrointest Endosc 90:360\u2013369. https:\/\/doi.org\/10.1016\/j.gie.2019.04.236","journal-title":"Gastrointest Endosc"},{"key":"4426_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen Y-J, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L et al (2021) Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:329\u2013359. https:\/\/doi.org\/10.6004\/jnccn.2021.0012","journal-title":"J Natl Compr Canc Netw"},{"key":"4426_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JGO.19.00367","volume":"6","author":"EG Chiorean","year":"2020","unstructured":"Chiorean EG, Nandakumar G, Fadelu T, Temin S, Alarcon-Rozas AE, Bejarano S, Croitoru AE, Grover S, Lohar PV, Odhiambo A et al (2020) Treatment of patients with late-stage colorectal cancer: ASCO resource-stratified guideline. JCO Glob Oncol 6:414\u2013438. https:\/\/doi.org\/10.1200\/JGO.19.00367","journal-title":"JCO Glob Oncol"},{"key":"4426_CR24","doi-asserted-by":"publisher","unstructured":"Yeom SS, Lee SY, Kwak HD, Kim CH, Kim YJ, Kim HR (2020) The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy. Medicine (Baltimore) 99:e19258. https:\/\/doi.org\/10.1097\/MD.0000000000019258","DOI":"10.1097\/MD.0000000000019258"},{"key":"4426_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13063-016-1164-0","volume":"17","author":"CW Kim","year":"2016","unstructured":"Kim CW, Baek JH, Choi GS, Yu CS, Kang SB, Park WC, Lee BH, Kim HR, Oh JH, Kim JH et al (2016) The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study protocol for a randomized controlled trial. Trials 17:34. https:\/\/doi.org\/10.1186\/s13063-016-1164-0","journal-title":"Trials"},{"key":"4426_CR26","doi-asserted-by":"publisher","unstructured":"Park EJ, Baek JH, Choi GS, Park WC, Yu CS, Kang SB, Min BS, Kim JH, Kim HR, Lee BH et al (2020) The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous, unresectable metastasis: a multicenter randomized controlled trial. Cancers (Basel) 12.\u00a0https:\/\/doi.org\/10.3390\/cancers12082306","DOI":"10.3390\/cancers12082306"},{"key":"4426_CR27","doi-asserted-by":"publisher","unstructured":"van der Kruijssen DEW, Elias SG, Vink GR, van Rooijen KL, \u2018t Lam-Boer J, Mol L, Punt CJA, de Wilt JHW, Koopman M, van Acker GJD et al (2021) Sixty-day mortality of patients with metastatic colorectal cancer randomized to systemic treatment vs primary tumor resection followed by systemic treatment. JAMA Surg 156.\u00a0https:\/\/doi.org\/10.1001\/jamasurg.2021.4992","DOI":"10.1001\/jamasurg.2021.4992"},{"key":"4426_CR28","doi-asserted-by":"publisher","unstructured":"Li H, Liu Q, Liang S, Yao P, Lv J, Wang G, Tang R, Zhao T, Li J, Xu L et al (2021) Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients. Transl Cancer Res 10:288\u2013297. https:\/\/doi.org\/10.21037\/tcr-20-2032","DOI":"10.21037\/tcr-20-2032"},{"key":"4426_CR29","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","volume":"139","author":"MY Kim","year":"2009","unstructured":"Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massague J (2009) Tumor self-seeding by circulating cancer cells. Cell 139:1315\u20131326. https:\/\/doi.org\/10.1016\/j.cell.2009.11.025","journal-title":"Cell"},{"key":"4426_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1067\/j.cpsurg.2018.08.004","volume":"55","author":"CL Stewart","year":"2018","unstructured":"Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, Kim JY, Fong Y (2018) Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg 55:330\u2013379. https:\/\/doi.org\/10.1067\/j.cpsurg.2018.08.004","journal-title":"Curr Probl Surg"},{"key":"4426_CR31","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/codi.15113","volume":"22","author":"M Milosevic","year":"2020","unstructured":"Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, Coonar A, Hasan J, Davidson B, Marchbank A et al (2020) Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed. Colorectal Dis 22:1314\u20131324. https:\/\/doi.org\/10.1111\/codi.15113","journal-title":"Colorectal Dis"},{"key":"4426_CR32","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1002\/bjs.11948","volume":"107","author":"T Treasure","year":"2020","unstructured":"Treasure T, Leonard P, Milosevic M, Williams NR, Macbeth F, Farewell V (2020) Pulmonary metastasectomy in colorectal cancer: the PulMiCC randomised controlled trial. Br J Surg 107:e489\u2013e490. https:\/\/doi.org\/10.1002\/bjs.11948","journal-title":"Br J Surg"},{"key":"4426_CR33","doi-asserted-by":"publisher","unstructured":"Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmaki A, Halonen P, Ristamaki R, Lantto E, Uutela A et al (2021) Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): a nationwide prospective intervention study. Lancet Reg Health Eur 3:100049. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100049","DOI":"10.1016\/j.lanepe.2021.100049"},{"key":"4426_CR34","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1245\/s10434-012-2382-7","volume":"19","author":"L Vigan\u00f2","year":"2012","unstructured":"Vigan\u00f2 L, Capussotti L, Barroso E, Nuzzo G, Laurent C, Ijzermans JNM, Gigot J-F, Figueras J, Gruenberger T, Mirza DF et al (2012) Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases. Ann Surg Oncol 19:2786\u20132796. https:\/\/doi.org\/10.1245\/s10434-012-2382-7","journal-title":"Ann Surg Oncol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-023-04426-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-023-04426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T11:23:48Z","timestamp":1703157828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-023-04426-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4426"],"URL":"https:\/\/doi.org\/10.1007\/s00384-023-04426-5","relation":{},"ISSN":["1432-1262"],"issn-type":[{"type":"electronic","value":"1432-1262"}],"subject":[],"published":{"date-parts":[[2023,5,27]]},"assertion":[{"value":"1 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data used in this study were obtained from publicly available database. Therefore, this study did not require the approval of the Ethics Committee of The First Affiliated Hospital of Anhui Medical University, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"144"}}